167 related articles for article (PubMed ID: 12131524)
1. Left ventricular hypertrophy and remodelling of resistance arteries: the role of activation of the renin-angiotensin-aldosterone system in hypertension.
Hayoz D
J Hypertens; 2002 Jul; 20(7):1295-6. PubMed ID: 12131524
[No Abstract] [Full Text] [Related]
2. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension.
Muiesan ML; Rizzoni D; Salvetti M; Porteri E; Monteduro C; Guelfi D; Castellano M; Garavelli G; Agabiti-Rosei E
J Hypertens; 2002 Jul; 20(7):1439-44. PubMed ID: 12131542
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
4. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Olsen MH; Wachtell K; Hermann KL; Frandsen E; Dige-Petersen H; Rokkedal J; Devereux RB; Ibsen H
Am Heart J; 2002 Sep; 144(3):530-7. PubMed ID: 12228792
[TBL] [Abstract][Full Text] [Related]
5. Local cardiac renin-angiotensin system: hypertension and cardiac failure.
Varagic J; Frohlich ED
J Mol Cell Cardiol; 2002 Nov; 34(11):1435-42. PubMed ID: 12431442
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE?
Lee KW; Lip GY
J Hum Hypertens; 2003 May; 17(5):299-304. PubMed ID: 12756401
[No Abstract] [Full Text] [Related]
7. Salt and left ventricular hypertrophy: what are the links?
Langenfeld MR; Schmieder RE
J Hum Hypertens; 1995 Nov; 9(11):909-16. PubMed ID: 8583471
[TBL] [Abstract][Full Text] [Related]
8. [Cardio-protection and cardio-reparation in systemic arterial hypertension].
Vallés Belsué F; Anguita Sánchez M
Rev Esp Cardiol; 1997; 50 Suppl 4():49-52. PubMed ID: 9411587
[TBL] [Abstract][Full Text] [Related]
9. [Angina pectoris and a normal coronary angiogram in arterial hypertension and left ventricular hypertrophy].
Motz W; Kelm M; Schwartzkopff B; Strauer BE
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1175-80. PubMed ID: 8076507
[No Abstract] [Full Text] [Related]
10. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
11. Vascular remodeling in hypertension: mechanisms and treatment.
Schiffrin EL
Hypertension; 2012 Feb; 59(2):367-74. PubMed ID: 22203749
[No Abstract] [Full Text] [Related]
12. Left ventricular hypertrophy in aortic valve stenosis: friend or foe?
Yotti R; Bermejo J
Heart; 2011 Feb; 97(4):269-71. PubMed ID: 21138860
[No Abstract] [Full Text] [Related]
13. [Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system].
Benetos A
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():21-4. PubMed ID: 7646306
[TBL] [Abstract][Full Text] [Related]
14. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
du Cailar G; Fesler P; Ribstein J; Mimran A
Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
[TBL] [Abstract][Full Text] [Related]
15. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
16. Quantification of the contribution of cardiac and arterial remodeling to hypertension.
Segers P; Stergiopulos N; Westerhof N
Hypertension; 2000 Nov; 36(5):760-5. PubMed ID: 11082140
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
J Cardiovasc Pharmacol; 2003 Dec; 42(6):719-26. PubMed ID: 14639093
[TBL] [Abstract][Full Text] [Related]
18. Contribution of increased minimal coronary resistance and attenuated vascular adaptive remodeling to myocardial ischemia in patients with systemic hypertension and ventricular hypertrophy.
Kataoka T; Hamasaki S; Ishida S; Saihara K; Okui H; Fukudome T; Shinsato T; Mizoguchi E; Ninomiya Y; Otsuji Y; Minagoe S; Tei C
Am J Cardiol; 2004 Aug; 94(4):484-7. PubMed ID: 15325935
[TBL] [Abstract][Full Text] [Related]
19. [Regression of left ventricular hypertrophy in essential arterial hypertension].
Román O
Rev Med Chil; 1994 Mar; 122(3):333-8. PubMed ID: 7809527
[TBL] [Abstract][Full Text] [Related]
20. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension.
Guimaraes DA; Batista RIM; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):9-17. PubMed ID: 32772466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
